Scientific in Biological Technology

National Institutes of Health Chooses Web of Science(R) to Power electronic Scientific Portfolio Assistant (eSPA)

PHILADELPHIA and LONDON, Aug. 3 /PRNewswire/ -- Thomson Reuters with Discovery Logic, Inc. today announced that the National Institutes of Health (NIH) has chosen Web of Science ((R)) data to power the NIH electronic Scientific Portfolio Assistant ( eSPA ). eSPA is an information tech...

Solace Pharmaceuticals Appoints Professor David Julius, Renowned Pain Physiologist, to Scientific Advisory Board

CAMBRIDGE, Mass., July 27 /PRNewswire/ -- Solace Pharmaceuticals, a private biotechnology company discovering and developing innovative treatments for pain, announced that David Julius, PhD, professor and chair of the department of physiology at the University of California, San Fra...

Irvine Scientific Announced Today a New Distribution Partnership With Prodimed

SANTA ANA, Calif. , July 21 /PRNewswire/ -- Irvine Scientific announced today a new distribution partnership with Prodimed, a company specializing in women's health, located in Neuilly en Thelle, France. Effective immediately, Irvine Scientific will be distributing Prodimed's extensive l...

New Scientific Worldview 'Biocentrism' Featured in The Huffington Post - #1 Weblog in the World

WORCESTER, Mass., July 14 /PRNewswire/ -- The Huffington Post -- 'The Internet Newspaper' -- featured today Dr. Robert Lanza's new book (co-authored with astronomer Bob Berman) " Biocentrism." The article by ACT's Lanza explains how life is the key to understanding the universe. The...

Brazil's Scientific Research On The Rise, Thomson Reuters Study Finds

PHILADELPHIA and LONDON, July 13 /PRNewswire/ -- Thomson Reuters today announced the results of a study documenting Brazil's steady rise during the last two decades in both the volume and impact of its scientific work. According to Science Watch , these findings underscore Brazil's sta...

Boston Scientific Announces European Approval for Its LATITUDE(R) Patient Management System

NATICK, Mass., July 13 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced CE Mark for its LATITUDE(R) Patient Management system. The LATITUDE system remotely monitors patients with implantable cardiac devices, gathering information on both the device and...

Stem Cell Cord Blood 'Banking' Is Huge Global Business for Hospitals, Says CEO of Bio-Matrix Scientific Group Inc.

SAN DIEGO, July 10 /PRNewswire-FirstCall/ -- David Koos, Chairman and CEO of San Diego-based Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN), today said that he believes that stem cell cord blood banking is a "huge business opportunity for hospitals worldwide." The Bio-Matrix CEO stat...

Covance Appoints Dr. Steven M. Michael as Vice President and Chief Scientific Officer of Global Bioanalytical Services

PRINCETON, N.J., July 7 /PRNewswire-FirstCall/ -- Covance Inc. today announced that Steven M. Michael, Ph.D. has joined the company as vice president and chief scientific officer of global bioanalytical services. With 15 years of pharmaceutical industry experience, including bioanalytical...

Kewaunee Scientific Reports Record Results Net Earnings for Year Increase 36%, Sales Increase 16%

STATESVILLE, N.C., June 24 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU ) today reported record sales, earnings, and order backlog for its fiscal year ended April 30, 2009. Net earnings for the year increased 36% to $4,247,000, or $1.66 per diluted share, up from...

Boston Scientific to Participate in Wachovia Conference

NATICK, Mass., June 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in the Wachovia 19th Annual Mid-Year Equity Conference, June 23 - 24. Jim Tobin, President and Chief Executive Officer, will make a 25-minute presentation on Wednesday, Ju...

iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board

SOUTH SAN FRANCISCO, Calif., June 11 /PRNewswire/ -- iZumi Bio, Inc., a biopharmaceutical company focused on the industrialization of induced pluripotent stem cell (iPS) technology with the mission of creating new therapeutics through cellular reprogramming and directed differentiation of patient ...

Intarcia Therapeutics, Inc. Presents ITCA 650 Phase 1b Study Results as a Late-Breaker at the American Diabetes Association 69th Scientific Sessions

DUROS(R) continuous delivery of exenatide produces impressive reductions in fasting plasma glucose, HbA1c and body weight during 28-day treatment NEW ORLEANS, June 8 /PRNewswire/ -- Intarcia Therapeutics, Inc. today presented results from the first clinical study of ITCA 650 (DUROS(R) continu...

Scripps Research Institute Highlights Groundbreaking Work of aTyr Pharma Scientific Co-Founder

Research Published by Scripps Associate Professor Xiang-Lei Yang Further Validates aTyr Pharma's Discovery Engine for Proprietary Drugs SAN DIEGO, June 8 /PRNewswire/ -- The June 1st, 2009 edition of The Scripps Research Institute (TSRI) News & Views highlights newly published researc...

Orexigen(R) Therapeutics Presents Additional NB-302 Contrave(R) Data at American Diabetes Association (ADA) 69th Scientific Sessions

SAN DIEGO , June 6 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ), a biopharmaceutical company focused on the treatment of obesity, today announced positive secondary findings from the first of four Phase 3 trials of its lead investigational product Contrave(R) (naltre...

Data for SemBioSys' insulin to be presented at the American Diabetes Association's 69th Scientific Sessions

CALGARY, June 5 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), specializing in the manufacture of high-value proteins and oils in plant seeds, today announced that it will present the recent results of the Phase I/II study with its biosimilar human insulin in a late-breaking scientifi...

Tobira Therapeutics Inc. Announces Key Addition to Scientific Advisory Board

- Dr. Roscoe M. Moore, Jr. to join Board - PRINCETON, N.J. and SAN DIEGO, June 4 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the...

EGEN, Inc. Announces the Promotion of Khursheed Anwer, Ph.D., to President and Chief Scientific Officer

HUNTSVILLE, Ala., June 3 /PRNewswire/ -- EGEN, Inc. (EGEN), a biopharmaceutical company specializing in nucleic acid therapeutics and delivery, announced today that Khursheed Anwer, Ph.D., has been promoted to President and Chief Scientific Officer. He will succeed Danny H. Lewis, Ph.D., who has ...

Orexigen(R) Therapeutics Announces Upcoming Data Presentations at American Diabetes Association and Endocrine Society Annual Scientific Meetings

SAN DIEGO, June 2 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX ) a biopharmaceutical company focused on the treatment of obesity, today announced the schedule of its upcoming Contrave(R) (naltrexone sustained release (SR)/bupropion SR) presentations taking place at the ...

Agendia Supports Genentech's Citizen's Petition Urging FDA to Hold In-Vitro Diagnostic Tests to One Set of Scientific and Regulatory Standards

HUNTINGTON BEACH, California, and AMSTERDAM, May 28 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced its strong support of Genentech's Citizen's Petition. Filed on December 5, 2008, Docket No. FDA-2008-P-0638-0001/CP petitions that all in vitro diagnosti...

Intarcia Therapeutics, Inc. Announces Acceptance of ITCA 650 Phase 1b Study for Late-Breaker Presentation at the American Diabetes Association 69th Scientific Sessions

First clinical study evaluating DUROS(R) continuous delivery of exenatide for the treatment of type 2 diabetes HAYWARD, Calif., May 27 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced it will present clinical data from a phase 1b study of ITCA 650 (DUROS(R) continuous delivery of e...

Simcere Pharmaceutical Group Appoints Dr. Peng Wang as Chief Scientific Officer

NANJING, China, May 19 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group (NYSE: SCR ), a leading manufacturer and supplier of branded generic and innovative anti-cancer pharmaceuticals in China, announced today the appointment of Dr. Peng Wang as Chief Scientific Officer. Dr. Wang wil...

Boston Scientific Welcomes Launch of Syntax Score Website

Online tools will help physicians determine treatment strategies NATICK, Mass. and BARCELONA, Spain, May 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today welcomed the launch of a new website, www.syntaxscore.com , dedicated to the understanding and use of the...

'Adipose-derived' Stem Cells Could Help Traumatic Brain Injury Patients, Says Bio-Matrix Scientific Group's, Entest BioMedical Inc. Researcher

SAN DIEGO, May 13 /PRNewswire-FirstCall/ -- Dr. Feng Lin, Director of Research at Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN) and Entest BioMedical Inc., today stated that he believes that an effective new therapy for "traumatic brain injury" (TBI) using autologous "adipose-derived...

Boston Scientific to Donate Cardiac Rhythm Management Devices to Heartbeat International for Implantation in Needy Patients

NATICK, Mass., May 13 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced that it has agreed to donate Cardiac Rhythm Management (CRM) devices, including pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices to Heartbea...

Boston Scientific Announces Company Schedule for Heart Rhythm Society Scientific Sessions

NATICK, Mass., May 11 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today announced the schedule of the Company's major events and news announcements at the 30th Annual Scientific Sessions of the Heart Rhythm Society, which run from May 13 to 16 in Boston. Highlights of t...

Bio-Matrix Scientific Group & Entest BioMedical Submit Research Proposal to U.S. Army for Funding Adipose-Derived Stem Cells to Treat Traumatic Brain Injury

SAN DIEGO, May 4 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN)( http://www.BMSN.us ) and Entest BioMedical Inc., its wholly owned subsidiary, announced today they have jointly submitted a Project Summary Report to the U.S. Army Medical Research and Mater...

E&K Scientific Announces Partnership with Sciformatix

Now Shipping SciLIMS Samples and Storage Management Product Line San Jose, CA (PRWEB) April 28, 2009 -- E&K Scientific , the premier provider of laboratory supplies and instrumentation to academic, biotech and pharmaceutical research laboratories, today announced t...

Cadence Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences

SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ) announced today that data from clinical trials of its investigational product candidate, Acetavance(TM) (intravenous acetaminophen), will be presented at the American Society of Regional Anesthesia and Pa...

Medivation Announces Upcoming Scientific Presentations at Medical Conferences

SAN FRANCISCO, April 23 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today announced several presentations at upcoming medical conferences that will feature its investigational drugs MDV3100 and Dimebon. MDV3100 2009 American Urological Association (AUA) Annual Meeting, ...

Bio-Matrix Scientific Group, Inc. Announces Preferred Stock Dividend and Spinoff of Wholly-Owned Subsidiary, Entest Biomedical, Inc.

SAN DIEGO, April 21 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN), a San Diego-based biotechnology research and development company, announced today that its Board of Directors has declared a stock dividend to common and preferred shareholders of record as ...

E&K Scientific Announces New Accuflow Product Line

E&K Scientific, the premier provider of laboratory supplies and instrumentation to academic, biotech and pharmaceutical research laboratories, today announced the release of its specialty Accuflow product line, supporting the local community and the environment. San...

Boston Scientific Announces First Quarter Special Items

NATICK, Mass., April 15 /PRNewswire-FirstCall/ -- Boston Scientific (NYSE: BSX ) today announced special items that will reduce its GAAP earnings for the first quarter. The Company plans to release its first quarter financial results on April 20. As the Company disclosed last month, the Co...

Stemedica Signs Scientific Advisory Board Agreement with Leading Pediatric Burn & Wound Care Researcher

Stemedica Cell Technologies, Inc., a leader in adult stem cell research and manufacturing, announced that Lee Ann Laurent-Applegate PD & MER has joined Stemedica's Scientific Advisory Board. In this capacity, she will help Stemedica advance the clinical development of a proprietary whole cel...

Paul Keim Appointed to febit's Scientific Advisory Board

Paul Keim brings deep knowledge in the field of medical microbiology, biodefense and pathogens to febit, the leader in microfluidic microarray DNA analysis technologies LEXINGTON, Mass. and HEIDELBERG, Germany, April 14 /PRNewswire/ -- febit today announced the recruitment of Paul Keim, P...

Amorcyte Reports Phase I Results of AMR-001 to Improve Recovery From Severe Heart Attack at ACC Annual Scientific Session

- First Stem Cell Trial to Show Dose-related Significant Improvement in Perfusion - ORLANDO, Fla., March 30 /PRNewswire/ -- Amorcyte, Inc. (Amorcyte) today announced data from its Phase I clinical trial of AMR-001, the company's lead product for the treatment of damaged heart muscle fol...

Otonomy Introduces Scientific Advisory Board

Company Assembles Physicians and Researchers Specializing in Ear Diseases to Guide Novel Treatments to Clinic SAN DIEGO, March 30 /PRNewswire/ -- Otonomy Inc. today introduced its scientific advisory board comprised of physicians and research scientists specializing in diseases and disorders ...

NIH News Confirms Trend in Stem Cell 'Storage' Facilities, says CEO of San Diego-based Bio-Matrix Scientific Group

SAN DIEGO, March 26 /PRNewswire-FirstCall/ -- David Koos, Chairman and CEO of San Diego-based Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN) announced today that the important discovery reported on Wednesday, March 25 by researchers at the National Institutes of Health (NIH; www.nih...

Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush

PARIS, March 26 /PRNewswire-FirstCall/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces today the appointment of Dr. Karen Bush to the Company's S...

Bio-Matrix Scientific Group CEO Tells Wall Street Transcript That 'Positive Cash Flow' Is Possible in '09; New Stem Cell Banking Facility Is Growth Vehicle Over the Next Two Years, Says CEO in Exclusive News Interview

SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- David Koos, Chairman and CEO of San Diego-based Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN), told the editors of The Wall Street Transcript, a New York City financial news weekly, that there is an excellent possibility that the company ...

Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development

SOUTH SAN FRANCISCO, Calif., March 24 /PRNewswire/ -- Catalyst Biosciences, Inc., a pioneer in the discovery and development of engineered proteases known as Alterase(TM) therapeutics, has appointed four new members to the company's Scientific Advisory Board (SAB). Robert J. Fletterick, Ph.D., Da...